De-escalating chemotherapy for stage I–II gastric neuroendocrine carcinoma? A real-world competing risk analysis

De-escalating chemotherapy for stage I–II gastric neuroendocrine carcinoma? A real-world competing risk analysis

Abstract Background The role of adjuvant chemotherapy in gastric neuroendocrine neoplasms (GNEC) has not been well clarified yet. The study was designed to investigate the potential effect of adjuvant chemotherapy in stage I–II GNEC patients and construct a predictive nomogram. Method Stage I–II GNE...

Full description

Bibliographic Details
Main Authors: Danwei Du, Yangyang Xie, Xiaowen Li, Zhongkai Ni, Jinbo Shi, Hai Huang
Format: Article
Language:English
Published: BMC 2023-05-01
Series:World Journal of Surgical Oncology
Subjects:
SEER Program
Nomogram
Chemotherapy
Gastric cancer
Competing risk analyses
Online Access:https://doi.org/10.1186/s12957-023-03029-2

Internet

https://doi.org/10.1186/s12957-023-03029-2

Similar Items